Workflow
公司财务
icon
Search documents
启明信息:2025一季报净利润-0.15亿 同比增长16.67%
Tong Hua Shun Cai Bao· 2025-04-28 08:14
数据四舍五入,查看更多财务数据>> 一、主要会计数据和财务指标 三、分红送配方案情况 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | -0.0368 | -0.0444 | 17.12 | 0.0279 | | 每股净资产(元) | 3.35 | 3.35 | 0 | 3.41 | | 每股公积金(元) | 0.71 | 0.71 | 0 | 0.72 | | 每股未分配利润(元) | 1.40 | 1.40 | 0 | 1.46 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.35 | 1.52 | -11.18 | 1.91 | | 净利润(亿元) | -0.15 | -0.18 | 16.67 | 0.11 | | 净资产收益率(%) | -1.09 | -1.32 | 17.42 | 0.82 | 本次公司不分配不转赠。 前十大流通股东累计持有: 23555.56万股,累计占流通股比: 57.66%, ...
康惠制药:2024年报净利润-0.9亿 同比下降246.15%
Tong Hua Shun Cai Bao· 2025-04-28 08:10
二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | -0.9000 | -0.2600 | -246.15 | -0.6300 | | 每股净资产(元) | 0 | 9.5 | -100 | 9.75 | | 每股公积金(元) | 4.13 | 4.13 | 0 | 4.13 | | 每股未分配利润(元) | 2.78 | 3.68 | -24.46 | 3.94 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 5.62 | 6.73 | -16.49 | 4.92 | | 净利润(亿元) | -0.9 | -0.26 | -246.15 | -0.63 | | 净资产收益率(%) | -9.92 | -2.72 | -264.71 | -6.24 | 数据四舍五入,查看更多财务数据>> 前十大流通股东累计持有: 6200.27万股,累计占流通股比: 62.0 ...
晶雪节能:2025一季报净利润0.03亿 同比下降25%
Tong Hua Shun Cai Bao· 2025-04-28 07:56
一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.0281 | 0.0394 | -28.68 | 0.0377 | | 每股净资产(元) | 0 | 7.74 | -100 | 7.48 | | 每股公积金(元) | 3.67 | 3.67 | 0 | 3.67 | | 每股未分配利润(元) | 2.68 | 2.64 | 1.52 | 2.42 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.01 | 1.07 | -5.61 | 1.02 | | 净利润(亿元) | 0.03 | 0.04 | -25 | 0.04 | | 净资产收益率(%) | 0.36 | 0.51 | -29.41 | 0.51 | 数据四舍五入,查看更多财务数据>> 本次公司不分配不转赠。 二、前10名无限售条件股东持股情况 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | ...
至正股份:2025一季报净利润-0.14亿 同比下降133.33%
Tong Hua Shun Cai Bao· 2025-04-28 07:52
一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | -0.1900 | -0.0700 | -171.43 | -0.0600 | | 每股净资产(元) | 0 | 3.37 | -100 | 3.98 | | 每股公积金(元) | 3.35 | 3.32 | 0.9 | 3.32 | | 每股未分配利润(元) | -1.72 | -1.19 | -44.54 | -0.58 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.51 | 0.37 | 37.84 | 0.28 | | 净利润(亿元) | -0.14 | -0.06 | -133.33 | -0.04 | | 净资产收益率(%) | -6.48 | -2.18 | -197.25 | -1.49 | 前十大流通股东累计持有: 2609.22万股,累计占流通股比: 35%,较上期变化: -302.12万股。 | 名称 | 持有 ...
中兰环保2024年报解读:营收净利双降,现金流承压
Xin Lang Cai Jing· 2025-04-28 07:31
Core Viewpoint - Zhonglan Environmental Technology Co., Ltd. faces significant challenges in its 2024 annual report, with major declines in key financial indicators, including a 144.48% decrease in net cash flow from operating activities and a 54.35% drop in net profit attributable to shareholders [1][2]. Financial Performance Overview - Revenue: The company reported operating revenue of 645.75 million yuan, a decrease of 22.75% year-on-year, primarily due to project delays in the pollution isolation system and renewable resource utilization segments, which saw declines of 48.10% and 60.52% respectively [2]. - Net Profit: The net profit attributable to shareholders was 13.10 million yuan, down 36.12% year-on-year, influenced by project delays and increased accounts receivable aging, leading to higher credit impairment losses [2]. - Basic Earnings Per Share: The basic earnings per share decreased to 0.13 yuan, a decline of 38.10% from the previous year, reflecting reduced profitability [3]. Expense Analysis - Overall Expenses: The company successfully reduced various expenses, with sales expenses down 27.25% to 17.53 million yuan and management expenses down 16.06% to 57.18 million yuan, attributed to strict cost control measures [4][5]. - Sales Expenses: The reduction in sales expenses was due to optimized sales strategies and adjustments in the compensation structure for sales personnel [5]. - Management Expenses: The decrease in management expenses resulted from meticulous management practices, including significant reductions in rent and utility costs [5]. Cash Flow Analysis - Operating Cash Flow: The net cash flow from operating activities was -57.11 million yuan, a decline of 144.48% year-on-year, indicating weakened cash collection capabilities [6][7]. - Investment Cash Flow: The net cash flow from investment activities improved to 34.05 million yuan from -148.41 million yuan, reflecting increased financial activities and recovery of investments [8]. - Financing Cash Flow: The net cash flow from financing activities decreased to -10.90 million yuan, down 315.95% year-on-year, primarily due to cash dividend payments [9]. Risk Insights - Industry Policy Risk: The environmental protection industry is heavily influenced by policy changes, which could significantly impact order acquisition and project implementation [10]. - Market Competition Risk: Increased competition from well-capitalized firms poses a risk to market share and profitability [11]. - Accounts Receivable Recovery Risk: The growing accounts receivable may lead to liquidity risks if external economic conditions affect customer payment capabilities [12].
苏州昊帆生物股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-27 22:48
Core Viewpoint - The company has disclosed its quarterly report, ensuring the accuracy and completeness of financial information, and has undertaken legal responsibilities for any misrepresentation or omissions [2][3]. Financial Data - The company has not restated or adjusted previous accounting data and confirms that non-recurring gains and losses are applicable, specifically mentioning the refund of personal income tax handling fees as a non-recurring item [3][4]. - As of February 5, 2025, the company has repurchased a total of 1,028,148 shares, accounting for 0.95% of the total share capital, with a total transaction amount of approximately 41.99 million yuan [6]. Shareholder Information - The company has not reported any changes in the top ten shareholders or the status of shares lent out for margin trading [5]. Other Important Matters - The company has established a wholly-owned subsidiary in Germany, "Highfine Biotech GmbH," with a registered capital of 200,000 euros, aimed at enhancing its competitive edge and expanding its market presence in Europe [7]. - The company’s production capacity is being expanded, with the first phase of its Anhui production base having commenced operations in August 2022, and a new project expected to obtain production licenses by January 2025 [9].
凯撒(中国)文化股份有限公司
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002425 证券简称:ST凯文 公告编号:2025-031 凯撒(中国)文化股份有限公司2025年第一季度报告 证券代码:002425 证券简称:ST凯文 公告编号:2025-031 凯撒(中国)文化股份有限公司 2025年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损 ...
朗新集团:2025一季报净利润0.03亿 同比增长115.79%
Tong Hua Shun Cai Bao· 2025-04-27 09:50
二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.0031 | -0.0180 | 117.22 | 0.0190 | | 每股净资产(元) | 6.47 | 6.98 | -7.31 | 6.53 | | 每股公积金(元) | 2.71 | 2.81 | -3.56 | 2.67 | | 每股未分配利润(元) | 2.77 | 3.26 | -15.03 | 2.91 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 6.67 | 6.68 | -0.15 | 6.53 | | 净利润(亿元) | 0.03 | -0.19 | 115.79 | 0.2 | | 净资产收益率(%) | 0.05 | -0.25 | 120 | 0.29 | 数据四舍五入,查看更多财务数据>> 三、分红送配方案情况 本次公司不分配不转赠。 前十大流通股东累计持有: 5 ...
安利股份:2025一季报净利润0.46亿 同比增长12.2%
Tong Hua Shun Cai Bao· 2025-04-27 09:41
前十大流通股东累计持有: 11065.27万股,累计占流通股比: 51.15%,较上期变化: -58.18万股。 数据四舍五入,查看更多财务数据>> 二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.2171 | 0.1930 | 12.49 | -0.0647 | | 每股净资产(元) | 6.8 | 6.02 | 12.96 | 5.82 | | 每股公积金(元) | 1.62 | 1.62 | 0 | 1.62 | | 每股未分配利润(元) | 3.54 | 2.84 | 24.65 | 2.55 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 5.55 | 5.41 | 2.59 | 4.34 | | 净利润(亿元) | 0.46 | 0.41 | 12.2 | -0.14 | | 净资产收益率(%) | 3.20 | 3.21 | -0. ...
ST目药:2025一季报净利润0.05亿 同比增长150%
Tong Hua Shun Cai Bao· 2025-04-27 09:24
| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.0418 | -0.0798 | 152.38 | -0.0744 | | 每股净资产(元) | 0.47 | 0.23 | 104.35 | -0.19 | | 每股公积金(元) | 1.34 | 1.34 | 0 | 0.6 | | 每股未分配利润(元) | -2.06 | -2.31 | 10.82 | -1.99 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.52 | 0.28 | 85.71 | 0.22 | | 净利润(亿元) | 0.05 | -0.1 | 150 | -0.09 | | 净资产收益率(%) | 9.27 | -30.12 | 130.78 | | 数据四舍五入,查看更多财务数据>> 一、主要会计数据和财务指标 三、分红送配方案情况 本次公司不分配不转赠。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况( ...